Pendal Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$572K Buy
3,240
+693
+27% +$120K ﹤0.01% 357
2022
Q3
$416K Sell
2,547
-42,799
-94% -$7.24M ﹤0.01% 363
2022
Q2
$8.05M Sell
45,346
-15,946
-26% -$2.84M 0.08% 118
2022
Q1
$10.9M Sell
61,292
-55,713
-48% -$9.48M 0.09% 117
2021
Q4
$20M Buy
117,005
+86,142
+279% +$14.1M 0.16% 91
2021
Q3
$4.98M Buy
30,863
+5,428
+21% +$926K 0.04% 143
2021
Q2
$4.19M Buy
25,435
+3,370
+15% +$558K 0.04% 161
2021
Q1
$3.63M Sell
22,065
-7,588
-26% -$1.23M 0.04% 167
2020
Q4
$4.67M Sell
29,653
-22,561
-43% -$3.33M 0.05% 127
2020
Q3
$7.77M Sell
52,214
-12,644
-19% -$1.87M 0.1% 83
2020
Q2
$9.12M Sell
64,858
-2,157
-3% -$314K 0.12% 75
2020
Q1
$8.79M Sell
67,015
-83,373
-55% -$11.8M 0.15% 63
2019
Q4
$21.9M Buy
150,388
+5,089
+4% +$690K 0.29% 48
2019
Q3
$18.8M Sell
145,299
-300
-0.2% -$39.5K 0.24% 52
2019
Q2
$20.3M Sell
145,599
-11,615
-7% -$1.61M 0.28% 56
2019
Q1
$22M Buy
157,214
+5,314
+3% +$712K 0.3% 57
2018
Q4
$19.6M Sell
151,900
-11,346
-7% -$1.58M 0.31% 59
2018
Q3
$22.6M Sell
163,246
-36,102
-18% -$4.8M 0.31% 58
2018
Q2
$24.2M Sell
199,348
-7,703
-4% -$961K 0.31% 58
2018
Q1
$26.5M Sell
207,051
-748
-0.4% -$101K 0.34% 48
2017
Q4
$29M Buy
207,799
+26,153
+14% +$3.64M 0.38% 46
2017
Q3
$23.7M Buy
181,646
+3,037
+2% +$403K 0.31% 60
2017
Q2
$23.6M Buy
+178,609
New +$22.8M 0.34% 60

Other funds holding JNJ

Pendal Group's JNJ Position: Q4 2022 in Review

Pendal Group increased its Johnson & Johnson (JNJ) stake by 27% in Q4 2022, buying an estimated $120K and bringing the position to 3,240 shares worth $572K. The position accounts for ﹤0.01% of the portfolio, ranked #357.

Pendal Group first reported a position in JNJ in Q2 2017 and has held it in 23 quarters since. The position peaked at $29M in Q4 2017. 3,788 funds tracked by Wall St. Rank hold JNJ as of Q4 2022.

  • Pendal Group held 3,240 shares of Johnson & Johnson worth $572K as of Q4 2022.
  • Pendal Group bought 693 Johnson & Johnson shares in Q4 2022, an estimated $120K.
  • Johnson & Johnson made up ﹤0.01% of Pendal Group's portfolio in Q4 2022, its #357 holding.
  • Pendal Group first reported a position in Johnson & Johnson in Q2 2017 and has held it in 23 quarters since.
  • Pendal Group's Johnson & Johnson position peaked at $29M in Q4 2017.
  • 3,788 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2022.

Based on Pendal Group's 13F filing for Q4 2022, filed 19 Jan 2023.